Phosphate binders and management of hyperphosphataemia in end-stage renal disease

Saved in:
Bibliographic Details
Published in:Nephrology, dialysis, transplantation dialysis, transplantation, 2006-08, Vol.21 (8), p.2065-2068
Main Authors: Savica, Vincenzo, Calò, Lorenzo A., Monardo, Pietro, Santoro, Domenico, Bellinghieri, Guido
Format: Article
Language:English
Subjects:
Acetates - therapeutic use
Aluminum Compounds - adverse effects
Aluminum Compounds - pharmacokinetics
Aluminum Compounds - therapeutic use
Bone Diseases, Metabolic - chemically induced
Bone Diseases, Metabolic - prevention & control
Calcinosis - etiology
Calcinosis - prevention & control
Calcium Carbonate - adverse effects
Calcium Carbonate - therapeutic use
Calcium Compounds - therapeutic use
Cardiovascular Diseases - etiology
Cardiovascular Diseases - prevention & control
Central Nervous System Diseases - chemically induced
Central Nervous System Diseases - prevention & control
Chronic Kidney Disease-Mineral and Bone Disorder - etiology
Chronic Kidney Disease-Mineral and Bone Disorder - prevention & control
Diet, Protein-Restricted
Ferric Compounds - therapeutic use
Humans
Hyperparathyroidism, Secondary - etiology
Hyperparathyroidism, Secondary - prevention & control
hyperphosphataemia
Kidney Failure, Chronic - blood
Kidney Failure, Chronic - complications
Kidney Failure, Chronic - diet therapy
Kidney Failure, Chronic - therapy
Lanthanum - pharmacokinetics
Lanthanum - therapeutic use
phosphate binders
Phosphates - blood
Phosphorus, Dietary - administration & dosage
Phosphorus, Dietary - adverse effects
Phosphorus, Dietary - pharmacokinetics
Polyamines - pharmacokinetics
Polyamines - therapeutic use
Renal Dialysis
renal failure
Sevelamer
vascular calcifications
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0931-0509
1460-2385
DOI:10.1093/ndt/gfl289